Alessandrea C. Quane - Jun 1, 2023 Form 4/A - Amendment Insider Report for Oscar Health, Inc. (OSCR)

Role: EVP, Chief Insurance Officer
Signature: /s/ Melissa Curtin, Attorney-in-Fact
Stock symbol: OSCR
Transactions as of: Jun 1, 2023
Transactions value $: -$116,717
Form type: 4/A - Amendment
Date filed: 8/15/2023, 05:18 PM
Date Of Original Report: Jun 5, 2023
Previous filing: Apr 3, 2023
Next filing: Jun 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OSCR	Class A Common Stock	Sale	-$117K	-16.3K	-7.11%	$7.15	213K	Jun 2, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F2	On June 5, 2023, the Reporting Person filed a Form 4 that inadvertently reported an incorrect price in Column 4, which was mischaracterized as a weighted average price. The price for this transaction is corrected in Column 4 of this amendment.